|

Anastrozole 1mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • European Organisation for Research and Treatment of Cancer - EORTC1

Indications

  • Stage III Breast Cancer1
  • Stage IIB Breast Cancer1
  • ER-positive Breast Cancer1
  • HER2-negative Breast Cancer1
  • Breast Cancer1

Other1 trial

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.